Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a buddy system help head and neck cancer patients? new study aims to find out

NCT ID NCT07664241

Symptom relief Sponsor: OHSU Knight Cancer Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times

Summary

This trial tests whether a one-on-one peer support program is feasible for people with head and neck cancer. Patients (mentees) are matched with cancer survivors (mentors) for emotional and informational support. The study will enroll 56 participants and measure how many actually meet their mentor and how satisfied they are. It does not test whether the program improves survival or cancer outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
peer support program
What this could lead to
If successful, this could show that a structured peer support program is a practical way to improve emotional and informational support for head and neck cancer patients.
What could go wrong
This is a small feasibility study (56 participants) that hasn't started recruiting yet. It only measures whether people use the program, not whether it improves health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 56 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 89 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * MENTEE GROUP: Ability to understand and the willingness to sign a written informed consent document * MENTEE GROUP: Willingness to have mentor-mentee interactions with the mentor selected by Imerman Angels (documented as part of informed consent) * MENTEE GROUP: Age 18 or older at the time of consent (upper age limit 89) * MENTEE GROUP: Diagnosed with head \& neck cancer (all stages) and planning to receive, currently receiving or recently completed (within 12 months) active treatment OR in follow-up and reporting unmet social/support needs * MENTEE GROUP: English-speaker * MENTEE GROUP: Access to electronic device that can be used for communication * MENTEE GROUP: Eastern Cooperative Oncology Group (ECOG) score less than or equal to 2 * CAREGIVER GROUP: Ability to understand and the willingness to sign a written informed consent document * CAREGIVER GROUP: Age 18 or older at the time of consent (upper age limit 89) * CAREGIVER GROUP: Caregiver of patient diagnosed with head and neck cancer who is also enrolled in the study * CAREGIVER GROUP: English-speaker * CAREGIVER GROUP: Access to electronic device that can be used for communication Exclusion Criteria: * MENTEE GROUP: Mentee must not be regularly engaging in other support programs at the start of the study intervention * MENTEE GROUP: Undergoing active professional treatment for cognitive or emotional difficulties or neurological deficits that preclude adherence to the study protocol * MENTEE GROUP: Any other social, emotional, or personal situation that will preclude adherence to the study protocol, at the discretion of the investigator * CAREGIVER GROUP: Caregivers must not be regularly engaging in other support programs at the start of the study intervention * CAREGIVER GROUP: Undergoing active professional treatment for cognitive or emotional difficulties or neurological deficits that preclude adherence to the study protocol * CAREGIVER GROUP: Any other social, emotional, or personal situation that will preclude adherence to the study protocol, at the discretion of the investigator

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Malignant head and neck neoplasm are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Malignant head and neck neoplasm

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • OHSU Knight Cancer Institute

    Portland, Oregon, 97239, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.